Ocular Therapeutix, Inc

OCUL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001393434

SEC filings (opens in a new tab)

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Ocular Therapeutix, Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of OCUL: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	114	119	+5
Shares	40.4M	73.7M	+33.3M (+82.4%)
Value	$127.0M	$328.8M	+$201.8M (+159.0%)

New holders (27)

Institutions that held Ocular Therapeutix, Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to OCUL in Q4 2023
Institution	Shares	Value	% of portfolio
Deep Track Capital, LP	9,230,769	$41.2M	1.44%
VR Adviser, LLC	7,775,760	$34.7M	2.38%
Franklin Resources Inc	4,500,159	$20.1M	0.01%
Logos Global Management LP	4,000,000	$17.8M	1.98%
Acuta Capital Partners, LLC	1,310,000	$5.84M	3.29%
Sio Capital Management, LLC	971,446	$4.33M	1.12%
Great Point Partners LLC	700,000	$3.12M	0.53%
Artia Global Partners LP	440,000	$1.96M	0.78%
Essex Investment Management Co LLC	370,372	$1.65M	0.33%
StemPoint Capital LP	279,648	$1.25M	0.34%
Legato Capital Management LLC	149,515	$666.8K	0.09%
Virtu Financial LLC	62,066	$277.0K	0.02%
Simplex Trading, LLC	59,115	$263.0K	0.01%
Aristides Capital LLC	50,226	$224.0K	0.11%
Sawtooth Solutions, LLC	44,987	$200.6K	0.01%
XTX Topco Ltd	27,942	$124.6K	0.03%
Pegasus Partners Ltd.	25,000	$111.5K	0.01%
Brevan Howard Capital Management LP	20,121	$89.7K	0.01%
Sherbrooke Park Advisers LLC	19,058	$85.0K	0.04%
Deerfield Management Company, L.P. (Series C)	18,987	$84.7K	0.00%
Relyea Zuckerberg Hanson LLC	17,600	$78.5K	0.02%
Squarepoint Ops LLC	13,944	$62.2K	0.00%
Coastal Bridge Advisors, LLC	12,900	$57.5K	0.01%
Victory Capital Management Inc	10,135	$45.2K	0.00%
River Wealth Advisors LLC	10,000	$44.6K	0.01%
nVerses Capital, LLC	–	$12.5K	0.03%
The PNC Financial Services Group, Inc.	11	$49	0.00%

Sold out (22)

Institutions that held Ocular Therapeutix, Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of OCUL in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Sectoral Asset Management Inc	969,350	$3.04M
Endurant Capital Management LP	353,707	$1.11M
Wellington Management Group LLP	305,216	$958.4K
Polar Asset Management Partners Inc.	263,763	$828.2K
Renaissance Technologies LLC	125,200	$393.0K
ExodusPoint Capital Management, LP	98,422	$309.0K
Graham Capital Management, L.P.	95,363	$299.4K
Mirae Asset Global Investments Co., Ltd.	52,049	$163.4K
Two Sigma Advisers, LP	33,700	$105.8K
Algert Global LLC	25,480	$80.0K
Levin Capital Strategies, L.P.	22,500	$70.7K
Ikarian Capital, LLC	21,590	$67.8K
Profund Advisors LLC	20,827	$65.4K
Archford Capital Strategies, LLC	20,000	$62.8K
Allspring Global Investments Holdings, LLC	16,081	$50.5K
Man Group plc	–	$50.3K
Rafferty Asset Management, LLC	11,837	$37.2K
Vontobel Holding Ltd.	10,000	$31.4K
Stephens Consulting, LLC	4,000	$12.6K
Belvedere Trading LLC	1,257	$3.95K
Ulland Investment Advisors, LLC	250	$1.00K
Massmutual Trust Co FSB	107	$336